BioCentury | Jan 24, 2018
Company News

Management tracks: Gritstone, Disarm, Symic

...of biochemical and cellular pharmacology at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). The International Myeloma Foundation...
BioCentury | Dec 16, 2017
Product Development

Assessing the BCMA scene

...and Brian Durie, a hematologist and oncologist at Cedars-Sinai Medical Center and chairman of the International Myeloma Foundation...
...Pink:GMXAY), Copenhagen, Denmark Genscript Biotech Corp. (HKSE:1548), Nanjing, China GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. International Myeloma Foundation...
BioCentury | Jan 26, 2015
Product Development

Takeda's patients

...Mosston said Millennium increased its relationships to more than 20 hematologic cancer groups, including the International Myeloma Foundation...
...NYSE:ANTM), Indianapolis, Ind. Fight Colorectal Cancer, Alexandria, Va. Friends of Cancer Research (FOCR), Washington, D.C. International Myeloma Foundation...
BioCentury | Jan 30, 2014
Translation in Brief

Translational tidbits

...Phase I/II single-agent and combination trials with GSK's early stage cancer pipeline Amgen Inc. (NASDAQ:AMGN) International Myeloma Foundation...
BioCentury | Dec 23, 2013
Company News

Amgen, International Myeloma Foundation deal

...disclose details, and the foundation could not be reached. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. International Myeloma Foundation...
BioCentury | Jun 25, 2012
Regulation

Singular exception

...median overall survival (OS) of 9 months. The data were from an analysis by the International Myeloma Foundation...
...Cleveland Clinic Taussig Cancer Institute , Cleveland, Ohio Emory School of Medicine , Atlanta, Ga. International Myeloma Foundation...
BioCentury | Apr 27, 2009
Regulation

Cost-sharing arithmetic

...taking the drug for a long time," said Brian Durie, chairman and medical director of International Myeloma Foundation...
...San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Health Service Executive , Dublin, Ireland International Myeloma Foundation...
BioCentury | Dec 22, 2008
Product Development

Looking to threepeat

...to Brian Durie, an attending physician at the Cedars-Sinai Medical Center and chairman of the International Myeloma Foundation...
...and Institutions Mentioned Cedars-Sinai Medical Center , Los Angeles, Calif. Celgene Corp. (NASDAQ:CELG), Summit, N.J. International Myeloma Foundation...
BioCentury | Dec 17, 2007
Product Development

Thinking through Velcade/Revlimid

...agreed Brian Durie, an attending physician at the Cedars-Sinai Medical Center and chairman of the International Myeloma Foundation...
BioCentury | Dec 6, 2004
Company News

OpGen management update

...CEO and a director, formerly president of Bank on a Cure, a project of the International Myeloma Foundation WIR...
Items per page:
1 - 10 of 11
BioCentury | Jan 24, 2018
Company News

Management tracks: Gritstone, Disarm, Symic

...of biochemical and cellular pharmacology at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY). The International Myeloma Foundation...
BioCentury | Dec 16, 2017
Product Development

Assessing the BCMA scene

...and Brian Durie, a hematologist and oncologist at Cedars-Sinai Medical Center and chairman of the International Myeloma Foundation...
...Pink:GMXAY), Copenhagen, Denmark Genscript Biotech Corp. (HKSE:1548), Nanjing, China GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. International Myeloma Foundation...
BioCentury | Jan 26, 2015
Product Development

Takeda's patients

...Mosston said Millennium increased its relationships to more than 20 hematologic cancer groups, including the International Myeloma Foundation...
...NYSE:ANTM), Indianapolis, Ind. Fight Colorectal Cancer, Alexandria, Va. Friends of Cancer Research (FOCR), Washington, D.C. International Myeloma Foundation...
BioCentury | Jan 30, 2014
Translation in Brief

Translational tidbits

...Phase I/II single-agent and combination trials with GSK's early stage cancer pipeline Amgen Inc. (NASDAQ:AMGN) International Myeloma Foundation...
BioCentury | Dec 23, 2013
Company News

Amgen, International Myeloma Foundation deal

...disclose details, and the foundation could not be reached. Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. International Myeloma Foundation...
BioCentury | Jun 25, 2012
Regulation

Singular exception

...median overall survival (OS) of 9 months. The data were from an analysis by the International Myeloma Foundation...
...Cleveland Clinic Taussig Cancer Institute , Cleveland, Ohio Emory School of Medicine , Atlanta, Ga. International Myeloma Foundation...
BioCentury | Apr 27, 2009
Regulation

Cost-sharing arithmetic

...taking the drug for a long time," said Brian Durie, chairman and medical director of International Myeloma Foundation...
...San Francisco, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Health Service Executive , Dublin, Ireland International Myeloma Foundation...
BioCentury | Dec 22, 2008
Product Development

Looking to threepeat

...to Brian Durie, an attending physician at the Cedars-Sinai Medical Center and chairman of the International Myeloma Foundation...
...and Institutions Mentioned Cedars-Sinai Medical Center , Los Angeles, Calif. Celgene Corp. (NASDAQ:CELG), Summit, N.J. International Myeloma Foundation...
BioCentury | Dec 17, 2007
Product Development

Thinking through Velcade/Revlimid

...agreed Brian Durie, an attending physician at the Cedars-Sinai Medical Center and chairman of the International Myeloma Foundation...
BioCentury | Dec 6, 2004
Company News

OpGen management update

...CEO and a director, formerly president of Bank on a Cure, a project of the International Myeloma Foundation WIR...
Items per page:
1 - 10 of 11